CymitQuimica logo

CAS 1216984-85-8

:

Rizatriptan-d6 Benzoate

Description:
Rizatriptan-d6 benzoate is a deuterated derivative of rizatriptan, a medication primarily used to treat migraines. The "d6" designation indicates that the compound contains six deuterium atoms, which are isotopes of hydrogen, replacing the regular hydrogen atoms in the molecular structure. This modification is often employed in research to enhance the stability and detectability of the compound in analytical studies, such as mass spectrometry. Rizatriptan itself is a selective agonist for serotonin receptors, particularly the 5-HT_1B and 5-HT_1D subtypes, which play a crucial role in the vasoconstriction of cranial blood vessels and the inhibition of pro-inflammatory neuropeptide release. The benzoate moiety suggests that the compound is in a salt form, which can influence its solubility and pharmacokinetic properties. Overall, rizatriptan-d6 benzoate serves as a valuable tool in pharmacological research, particularly in studies involving drug metabolism and receptor binding assays.
Formula:C22H24N5O2
Synonyms:
  • N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine-d6 Benzoate
  • Rizatriptan-d6 Benzoate
  • MK-462-d6
  • Maxalt-d6
  • MK-0462-d6
  • N,N-(DiMethyl-d6)-5-(1H-1,2,4-triazol-1-ylMethyl)-1H-indole-3-ethanaMine Benzoate
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 4 products.